Eli Lilly’s UK life sciences investment ‘a pivotal moment’, says analyst
Eli Lilly’s investment is seen as an opportunity to drive economic growth for the UK while improving public health.
Themes
Pharma’s data and analytics market forecast to reach to $2.1bn by 2028
Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19
Novo Nordisk invests $1.2bn in new Denmark facility
Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
ASH 2024 discussions shine spotlight on advances in haemophilia treatments
Vifor Pharma offers £23m to NHS to resolve CMA investigation
ASH 2024: Regeneron’s Ordspono faces challenges, but positive results signal hope
